Targeting GRPR in urological cancers--from basic research to clinical application

Gastrin releasing peptide (GRP) is a regulatory peptide that acts through its receptor (GRPR) to regulate physiological functions in various organs. GRPR is overexpressed in neoplastic cells of most prostate cancers and some renal cell cancers and in the tumoral vessels of urinary tract cancers. Thus, targeting these tumours with specifically designed GRP analogues has potential clinical application. Potent and specific radioactive, cytotoxic or nonradioactive GRP analogues have been designed and tested in various animal tumour models with the aim of receptor targeting for tumour diagnosis or therapy. All three categories of compound were found suitable for tumour targeting in animal models. The cytotoxic and nonradioactive GRP analogues have not yet shown convincing tumour-reducing effects in human trials; however, the first clinical studies of radioactive GRP analogues--both agonists and antagonists--suggest promising opportunities for both diagnostic tumour imaging and radiotherapy of prostate and other GRPR-expressing cancers.

The use of plant-based bioassays in homeopathic basic research.

OBJECTIVES The objective was to evaluate homeopathic basic research studies that use plant-based bioassays. With this in view, a compilation was made of the findings of three systematic literature reviews covering plant-based bioassays in the three fields of healthy, abiotically, or biotically stressed plants. This compilation focused on investigations using advanced experimental methods and detailed descriptions, also with the aim of supporting the design of future experiments. METHODS Publications included had to report on studies into the effects of homeopathic preparations on whole plants, seeds, plant parts and cells. Outcomes had to be measured by established procedures and statistically evaluated. A Manuscript Information Score (MIS) was applied using predefined criteria to identify publications with sufficient information for adequate interpretation (MIS ≥ 5). Additional evaluation focused on the use of adequate controls to investigate specific effects of homeopathic preparations, and on the use of systematic negative control (SNC) experiments to ensure the stability of the bioassay. Only a fraction of the studies reported here were performed with 'ultra high' dilutions, whereas other studies were performed with moderate or high dilutions. RESULTS A total of 157 publications were identified, describing a total of 167 experimental studies. 84 studies included statistics and 48 had a MIS ≥ 5, thus allowing adequate interpretation. 29 studies had adequate controls to identify specific effects of homeopathic preparations, and reported significant effects of decimal and centesimal homeopathic potencies, including dilution levels beyond Avogadro's number. 10 studies reported use of SNC experiments, yielding evidence for the stability of the experimental set-up. CONCLUSION Plant models appear to be a useful approach for investigating basic research questions relating to homeopathic preparations, but more independent replication trials are needed in order to verify the results found in single experiments. Adequate controls and SNC experiments should be implemented on a routine basis to exclude false-positive results.

Summaries of the UDAEC basic research programs in metallurgy, solid state physics and ceramics.

"January 1964 (DTIE Issuance Date)."

Summaries of the UDAEC basic research programs in metallurgy, solid state physics and ceramics : (fiscal year 1964)

"January 1965 (DTIE Issuance Date)."

Summaries of the USAEC basic research program in chemistry : (off site).

Includes indexes.

Summaries of the USAEC basic research program in chemistry : (off site) /

"TID-4500(46th Ed.)."

Summaries of the USAEC basic research program in chemistry : (on site) /

"(TID-4500, 33rd. Ed.).

Summaries of the UDAEC basic research programs in metallurgy, solid state physics and ceramics.

"June 1961 (OIT Issuance Date)."

Cocaine and a changing brain : meeting summary : Ernest Morial Convention Center, New Orleans, LA, October 25, 1997 : sponsored by Division of Basic Research, National Institute on Drug Abuse, National Institutes of Health /

"January 1999"--P. [4] of cover.

Basic research in crashworthiness II - low speed impact tests of unmodified vehicles. Interim technical report.

National Highway Traffic Safety Administration, Washington, D.C.

Basic research in crashworthiness II - development of moving barrier test technique. Interim technical report.

National Highway Traffic Safety Administration, Washington, D.C.

Basic research into crashworthiness of vehicle structures. Technical report.

National Highway Safety Bureau, Washington, D.C.

Basic research in crashworthiness II - low speed impact tests of modified vehicles. Interim technical report.

National Highway Traffic Safety Administration, Washington, D.C.